Brief Amici Curiae of Professors Roger Sperry, Gerald Holton, Everett Mendelsohn and Dorothy Nelkin in suppport of Petitioners, Genetics Institute Inc., et. al. v. Amgen Inc., 502 U.S. 856 (1991)

    Research output: Other contribution

    Abstract

    The Federal Circuit Court's decision in this case alters the bargain struck by Congress between the public and inventors by allowing the inventors of genetically engineered cell lines to withhold the exact nature of the cells from the public. Established law and policy have heretofore required patent applicants whose inventions involve new or unique biological material to place samples of their cells in public culture depositories.

    Original languageAmerican English
    StatePublished - Aug 27 1991

    Keywords

    • patent
    • full disclosure
    • deposit requirement
    • genetics
    • gene
    • biotechnology

    Disciplines

    • Intellectual Property Law

    Cite this